Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.56 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.56 |
| ▸ | CALCR | P30988 | 3/20 | 0.55 |
| ▸ | AGTR2 | P50052 | 3/20 | 0.52 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.52 |
| ▸ | BACE1 | P56817 | 1/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 6/20 | 0.50 |
| ▸ | NPY4R | P50391 | 6/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.50 |
| ▸ | NPY1R | P25929 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30296696 | 0.97 | CALCR (0.54) | CRHR1CRHR2CALCRAGTR2AGTR1 | |
| SCHEMBL29501059 | 0.88 | BACE1 (0.59) | CRHR1CRHR2CALCRAGTR2AGTR1 | |
| SCHEMBL30363005 | 0.87 | BACE1 (0.58) | CRHR1CRHR2CALCRAGTR2AGTR1 | |
| SCHEMBL30362923 | 0.87 | BACE1 (0.58) | CRHR1CRHR2CALCRAGTR2AGTR1 | |
| SCHEMBL30362943 | 0.87 | BACE1 (0.58) | CRHR1CRHR2CALCRAGTR2AGTR1 | |
| SCHEMBL30363072 | 0.87 | BACE1 (0.58) | CRHR1CRHR2CALCRAGTR2AGTR1 | |
| SCHEMBL30761771 | 0.87 | BACE1 (0.58) | CRHR1CRHR2CALCRAGTR2AGTR1 | |
| SCHEMBL29693043 | 0.87 | BACE1 (0.58) | CRHR1CRHR2CALCRAGTR2AGTR1 | |
| SCHEMBL38663746 | 0.87 | CALCR (0.65) | CRHR1CRHR2CALCRNPY2RNPY4R | |
| SCHEMBL30362915 | 0.87 | CALCR (0.55) | CRHR1CRHR2CALCRAGTR2AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190952-A1 | IL-18 Binding Protein (IL-18BP) and Antibodies for Treating Inflammatory Diseases | AB2 BIO SA (CH) | 2024-06-13 | — | — | US | disclosed |
| US-11820817-B2 | IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases | AB2 BIO SA (CH) | 2023-11-21 | — | — | US | disclosed |
| US-20230250164-A1 | IL-18 Binding Protein (IL-18BP) In Inflammatory Diseases | AB2 BIO SA (CH) | 2023-08-10 | — | — | US | disclosed |
| US-11530263-B2 | IL-18 binding protein (IL-18BP) in inflammatory diseases | AB2 BIO SA (CH) | 2022-12-20 | — | — | US | disclosed |
| EP-3978526-A1 | IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES | AB2 Bio SA (CH) | 2022-04-06 | — | — | EP | disclosed |